Skip to main content

Wagner Charles F Jr's Form 4 filing

Vertex Pharmaceuticals Inc (VRTX) · filed May 4, 2022

Accession no.
0000899243-22-016635
Filed
May 4, 2022
Trade date
May 2, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 7 non-derivative transactions. Open-market sales total $88.8K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Wagner Charles F JrCIK 0001223348Officer (EVP & Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 2, 2022Common StockSSaleDisposed−20$254.87−$5,097.443,053Direct
May 2, 2022Common StockSSaleDisposed−100$257.18F2,F3−$25,71842,953Direct
May 2, 2022Common StockSSaleDisposed−60$258.21F2,F4−$15,492.642,893Direct
May 2, 2022Common StockSSaleDisposed−80$259.45F2,F5−$20,75642,813Direct
May 2, 2022Common StockSSaleDisposed−48$261.15F2,F6−$12,535.242,765Direct
May 2, 2022Common StockSSaleDisposed−32$262.06F2,F7−$8,385.9242,733Direct
May 2, 2022Common StockSSaleDisposed−3$264.37−$793.1142,730Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Referenced by the price of 5 transactions in Table I.

F3

Open market sales reported on this line occurred at a weighted average price of $257.18 (range $256.68 to $257.47).

Referenced by the price of 1 transaction in Table I.

F4

Open market sales reported on this line occurred at a weighted average price of $258.21 (range $257.98 to $258.61).

Referenced by the price of 1 transaction in Table I.

F5

Open market sales reported on this line occurred at a weighted average price of $259.45 (range $258.98 to $259.90).

Referenced by the price of 1 transaction in Table I.

F6

Open market sales reported on this line occurred at a weighted average price of $261.15 (range $260.79 to $261.63).

Referenced by the price of 1 transaction in Table I.

F7

Open market sales reported on this line occurred at a weighted average price of $262.06 (range $261.89 to $262.23).

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)